Dose Response Study in Japanese Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

October 31, 2005

Conditions
Type 2 Diabetes
Interventions
DRUG

Tesaglitazar

Trial Locations (20)

Unknown

Research Site, Ashino

Research Site, Fuchu Keijinkai

Research Site, Fujimino

Research Site, Hijirino Koike

Research Site, Houseikai

Research Site, Hyūga

Research Site, Iriuchijima

Research Site, Iwase

Research Site, Katō

Research Site, Kawamata

Research Site, Keishukai Shirakawa

Research Site, Koga

Research Site, Kōhoku

Research Site, Kōsei

Research Site, Kurosawa

Research Site, Nihonmatu

Research Site, Oki

Research Site, Saiseikai Fukuoka

Research Site, Sapporo

Research Site, Takamori

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY